Clinical and economical impact of 2010 AASLD guidelines for the diagnosis of hepatocellular carcinoma

Journal of Hepatology

Volumn 60, Issue 5, 2014, Pages 995-1001

  Manini, Matteo Angelo ^a   Sangiovanni, Angelo ^a   Fornari, Fabio ^b   Piscaglia, Fabio ^c   Biolato, Marco ^d   Fanigliulo, Libera ^b   Ravaldi, Elisa ^c   Grieco, Antonio ^d   Colombo, Massimo ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b GUGLIELMO DA SALICETO HOSPITAL   (Italy)

^c UNIVERSITY OF BOLOGNA   (Italy)

^d CATHOLIC UNIVERSITY   (Italy)

Author keywords

Cirrhosis; Clinical guidelines; Hepatocellular carcinoma; Imaging techniques; Surveillance

Indexed keywords

CONTRAST MEDIUM;

ADULT; AGED; ALGORITHM; CARCINOMA, HEPATOCELLULAR; CLINICAL TRIAL; COMPLICATION; COMPUTER ASSISTED TOMOGRAPHY; COST; DIAGNOSTIC ERROR; DIAGNOSTIC USE; ECHOGRAPHY; ECONOMICS; FEMALE; FINE NEEDLE ASPIRATION BIOPSY; HUMAN; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; MEDICAL SOCIETY; MIDDLE AGED; MULTICENTER STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRACTICE GUIDELINE; PROSPECTIVE STUDY; UNITED STATES; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ALGORITHMS; BIOPSY, FINE-NEEDLE; CARCINOMA, HEPATOCELLULAR; CONTRAST MEDIA; COSTS AND COST ANALYSIS; DIAGNOSTIC ERRORS; FEMALE; HUMANS; LIVER CIRRHOSIS; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PRACTICE GUIDELINES AS TOPIC; PROSPECTIVE STUDIES; SOCIETIES, MEDICAL; TOMOGRAPHY, X-RAY COMPUTED; ULTRASONOGRAPHY; UNITED STATES;

EID: 84898833685     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2014.01.006     Document Type: Article

References (18)

1. M. Sherman, J. Bruix, and M. Porayko Tran T for the AASLD Practice Guidelines Committee. Screening for hepatocellular carcinoma: the rationale for the American Association for the Study of Liver Diseases recommendations Hepatology 56 2012 793 796
2. J. Bruix, and M. Sherman American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma: an update Hepatology 53 2011 1020 1022
3. European Association for Study of Liver European Organisation for Research and Treatment of Cancer. EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma J Hepatol 56 2012 908 943
4. M. Omata, L.A. Lesmana, R. Tateishi, P.J. Chen, S.M. Lin, and H. Yoshida et al. Asian pacific association for the study of the liver consensus recommendations on hepatocellular carcinoma Hepatol Int 4 2010 439 474
5. SonoVue (sulphur hexafluoride microbubbles) - contrast agent for contrast enhanced ultrasound imaging of the liver. August; 2012. http://publications. nice.org.uk/dg5.
6. M. Claudon, C.F. Dietrich, B.I. Choi, D.O. Cosgrove, M. Kudo, and C.P. Nolsøe et al. Guidelines and Good Clinical Practice Recommendations for Contrast Enhanced Ultrasound (CEUS) in the Liver - Update 2012 Ultraschall Med 34 2013 11 29
7. J. Bruix, and M. Sherman Practice Guidelines Committee, American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma Hepatology 42 2005 1208 1236
8. M. Borzio, F. Fornari, I. De Sio, A. Andriulli, F. Terracciano, and G. Parisi et al. Adherence to American Association for the Study of Liver Diseases guidelines for the management of hepatocellular carcinoma: results of an Italian field practice multicenter study Future Oncol 9 2013 283 294
9. A. Sangiovanni, M.A. Manini, M. Iavarone, R. Romeo, L.V. Forzenigo, and M. Fraquelli et al. The diagnostic and economic impact of contrast imaging techniques in the diagnosis of small hepatocellular carcinoma in cirrhosis Gut 59 2010 638 644
10. S. Leoni, F. Piscaglia, R. Golfieri, V. Camaggi, G. Vidili, and P. Pini et al. The impact of vascular and nonvascular findings on the noninvasive diagnosis of small hepatocellular carcinoma based on the EASL and AASLD criteria Am J Gastroenterol 105 2010 599 609
11. M. Pompili, L. Riccardi, S. Semeraro, R. Orefice, F. Elia, and B. Barbaro et al. Contrast-enhanced ultrasound assessment of arterial vascularization of small nodules arising in the cirrhotic liver Dig Liver Dis 40 2008 206 215
12. S. Gaiani, N. Celli, F. Piscaglia, L. Cecilioni, F. Losinno, and F. Giangregorio et al. Usefulness of contrast-enhanced perfusional sonography in the assessment of hepatocellular carcinoma hypervascular at spiral computed tomography J Hepatol 41 2004 421 426
13. A. Gatto, A.M. De Gaetano, M. Giuga, M. Ciresa, L. Siciliani, and L. Miele et al. Differentiating hepatocellular carcinoma from dysplastic nodules at gadobenate dimeglumine-enhanced hepatobiliary-phase magnetic resonance imaging Abdom Imaging 2012 10.1007/s00261-012-9950-y [Epub ahead of print]
14. R. Golfieri, M. Renzulli, V. Lucidi, B. Corcioni, F. Trevisani, and L. Bolondi Contribution of the hepatobiliary phase of Gd-EOB-DTPA-enhanced MRI to Dynamic MRI in the detection of hypovascular small (≤2 cm) HCC in cirrhosis Eur Radiol 21 2011 1233 1242
15. International Working Party Terminology of nodular hepatocellular lesions Hepatology 22 1995 983 993
16. A. Forner, R. Vilana, C. Ayuso, L. Bianchi, M. Solé, and J.R. Ayuso et al. Diagnosis of hepatic nodules 20 mm or smaller in cirrhosis: prospective validation of the noninvasive diagnostic criteria for hepatocellular carcinoma Hepatology 47 2008 97 104
17. K. Khalili, T.K. Kim, H.J. Jang, M.A. Haider, L. Khan, and M. Guindi et al. Optimization of imaging diagnosis of 1-2 cm hepatocellular carcinoma: an analysis of diagnostic performance and resource utilization J Hepatol 54 2011 723 728
18. T. Sersté, V. Barrau, V. Ozenne, M.P. Vullierme, P. Bedossa, and O. Farges et al. Accuracy and disagreement of computed tomography and magnetic resonance imaging for the diagnosis of small hepatocellular carcinoma and dysplastic nodules: role of biopsy Hepatology 55 2012 800 806